8-Bromo-2,3-dihydro-4(1H)-quinolinone

• CAS: 38470-29-0
• Catalog Number: ACM38470290
• Category: Quinolines
• Molecular Weight: 226.07
• Molecular Formula: C9H8BrNO
• Melting Point: 53-58 °C
• Appearance: Powder or Crystals

Custom Q&A

What is the molecular formula of 8-Bromo-2,3-dihydro-4(1H)-quinolinone?

The molecular formula of 8-Bromo-2,3-dihydro-4(1H)-quinolinone is C9H8BrNO.

What is the molecular weight of 8-Bromo-2,3-dihydro-4(1H)-quinolinone?

The molecular weight of 8-Bromo-2,3-dihydro-4(1H)-quinolinone is 226.07 g/mol.

What is the IUPAC name of 8-Bromo-2,3-dihydro-4(1H)-quinolinone?

The IUPAC name of 8-Bromo-2,3-dihydro-4(1H)-quinolinone is 8-bromo-2,3-dihydro-1H-quinolin-4-one.

What is the InChIKey of 8-Bromo-2,3-dihydro-4(1H)-quinolinone?

The InChIKey of 8-Bromo-2,3-dihydro-4(1H)-quinolinone is UHCQKTPURTYSFF-UHFFFAOYSA-N.

How many hydrogen bond donor counts does 8-Bromo-2,3-dihydro-4(1H)-quinolinone have?

8-Bromo-2,3-dihydro-4(1H)-quinolinone has 1 hydrogen bond donor count.

What is the topological polar surface area of 8-Bromo-2,3-dihydro-4(1H)-quinolinone?

The topological polar surface area of 8-Bromo-2,3-dihydro-4(1H)-quinolinone is 29.1 Å2.

How many hydrogen bond acceptor counts does 8-Bromo-2,3-dihydro-4(1H)-quinolinone have?

8-Bromo-2,3-dihydro-4(1H)-quinolinone has 2 hydrogen bond acceptor counts.

Is 8-Bromo-2,3-dihydro-4(1H)-quinolinone a canonicalized compound?

Yes, 8-Bromo-2,3-dihydro-4(1H)-quinolinone is a canonicalized compound.

What is the formal charge of 8-Bromo-2,3-dihydro-4(1H)-quinolinone?

The formal charge of 8-Bromo-2,3-dihydro-4(1H)-quinolinone is 0.

How many defined atom stereocenter counts does 8-Bromo-2,3-dihydro-4(1H)-quinolinone have?

8-Bromo-2,3-dihydro-4(1H)-quinolinone has 0 defined atom stereocenter counts.

Synthetic Use

Upstream Synthesis Route 1

• 38470-20-1

• 38470-29-0

Reference: [1]Current Patent Assignee: RYVU THERAPEUTICS SA - WO2020/249773, 2020, A1
Location in patent: Page/Page column 94-95; 150-151
[2]Current Patent Assignee: ARBUTUS BIOPHARMA CORP - WO2018/52967, 2018, A1
Location in patent: Page/Page column 161
[3]Current Patent Assignee: MOCHIDA PHARMACEUTICAL CO LTD - EP1582520, 2005, A1
Location in patent: Page/Page column 20

Downstream Synthesis Route 1

• 38470-29-0
• 2537-48-6

• 1169856-98-7

Reference: [1]Current Patent Assignee: GLAXOSMITHKLINE PLC - WO2009/86139, 2009, A1
Location in patent: Page/Page column 143

* For details of the synthesis route, please refer to the original source to ensure accuracy.